首站-论文投稿智能助手
典型文献
Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19:A case report
文献摘要:
This report presents the case of a 59-year-old man with severe COVID-19 that gradually progressed to cytokine release syndrome and then acute respiratory distress syndrome;he was successfully treated via integration of therapeutic plasma exchange and traditional Chinese medicine.The patient initially presented with a sore throat,severe muscle aches,productive cough and fever.On the worsening of symptoms,remdesivir was administered.However,as the symptoms continued to worsen and a cytokine release syndrome was suspected,oxygen was provided through a high-flow nasal cannula(50 L/min)and therapeutic plasma exchange was performed to prevent worsening of the acute respiratory distress syn-drome.On the same day,a course of traditional Chinese medicine was introduced in consultation with the infectious house staff.The patient's symptoms gradually improved;the levels of C-reactive protein and D-dimers reduced,and the patient was weaned to a simple oxygen mask and eventually to room air.This is the first reported case of the integration of these treatments.Together,they prevented the patient from requiring intubation,played a role in cytokine management,and also improved the clinical symptoms,including productive purulent sputum,cough,frequent stool passage and intermittent fever,with no adverse effects.As a result,the patient was discharged within two weeks of the integration of these treatments.Therefore,the integration of therapeutic plasma exchange and traditional Chinese medicine is an effective therapy for patients with severe COVID-19.
文献关键词:
作者姓名:
Chia-Wei Lin;Wei-Chen Hsu;Chien-Lu Lu;Su-Hsing Cheng;Cheng-Pin Chen;Yu-Chang Hou
作者机构:
Department of Chinese Medicine,Taoyuan General Hospital,Taoyuan City 330,Taiwan,China;Department of Nephrology,Taoyuan General Hospital,Taoyuan City 330,Taiwan,China;Department of Infectious Disease,Taoyuan General Hospital,Taoyuan City 330,Taiwan,China;School of Public Health,Taipei Medical University,Taipei City 110,Taiwan.China;Department of Bioscience Technology,Chung Yuan Christian University,Taoyuan City 320,Taiwan,China;School of Chinese Medicine,College of Chinese Medicine,China Medical University,Taichung City 404,Taiwan,China;School of Traditional Chinese Medicine,College of Medicine,Chang Gung University,Taoyuan City 333,Taiwan,China
引用格式:
[1]Chia-Wei Lin;Wei-Chen Hsu;Chien-Lu Lu;Su-Hsing Cheng;Cheng-Pin Chen;Yu-Chang Hou-.Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19:A case report)[J].结合医学学报(英文版),2022(06):575-580
A类:
B类:
Integrated,therapeutic,plasma,exchange,traditional,Chinese,medicine,severe,case,This,presents,year,old,that,gradually,progressed,cytokine,release,syndrome,then,acute,respiratory,distress,was,successfully,treated,via,integration,initially,presented,sore,throat,muscle,aches,productive,cough,fever,On,worsening,symptoms,remdesivir,administered,However,continued,suspected,oxygen,provided,through,high,flow,nasal,cannula,performed,same,day,course,introduced,consultation,infectious,house,staff,improved,levels,reactive,protein,dimers,reduced,weaned,simple,mask,eventually,room,air,first,reported,these,treatments,Together,they,prevented,from,requiring,intubation,played,role,management,also,clinical,including,purulent,sputum,frequent,stool,passage,intermittent,no,adverse,effects,result,discharged,within,two,weeks,Therefore,effective,therapy,patients
AB值:
0.539723
相似文献
Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid
Xiaojuan Jiang;Yihua Lin;Yunlong Wu;Caixia Yuan;Xuli Lang;Jiayun Chen;Chunyan Zhu;Xinyi Yang;Yu Huang;Hao Wang;Caisheng Wu-Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology,School of Pharmaceutical Sciences,Xiamen University,Xiamen,Fujian,361102,China;Department of Respiratory and Critical Care Medicine,The Third Clinical Medical College,Fujian Medical University,Fuzhou,350122,China;Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,361003,China;Laboratory of Pharmacology/Beijing Key Laboratory of Antimicrobial Agents,Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100050,China;School of Pharmacy,Ningxia Medical University,Yinchuan,750004,China;School of Pharmacy,Minzu University of China,Beijing,100081,China;Key Laboratory of Ethnomedicine(Minzu University of China),Ministry of Education,Beijing,100081,China;Institute of National Security,Minzu University of China,Beijing,100081,China
Assessment of traditional Chinese medicine pattern in a bleomycin-induced pulmonary fibrosis mouse model:A pilot study
Xiaofeng Gu;Wan Wei;Zhaoheng Liu;Fang Cao;Zhisong Wu;Jie Xie;Tianfang Wang;Yang Jiao-Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,310003,China;Department of Geriatrics,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China;School of Life Sciences,Beijing University of Chinese Medicine,Beijing,102488,China;Department of Intensive Cae Unit.Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China;School of Postgraduate,Beijing University of Chinese Medicine,Beijing,100029,China;School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,102488,China;Department of Respiratory,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Effect of treatment with Fufang Huangqi decoction(复方黄杞汤剂)on dose reductions and discontinuation of pyridostigmine bromide tablets,prednisone,and tacrolimus in patients with type Ⅰ or Ⅱ myasthenia gravis
SHAN Caifeng;ZHANG Jingsheng;LIN Yi;HUANG Xueshi;WANG Zhanyou;PAN Haiou;QIAO Wenjun-the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Liaoning Provincial Key Laboratory for Diagnosis and Treatment of Myasthenia Gravis,Liaoning University of Traditional Chinese Medicine,Shenyang 110033,China;Department of General Surgery,the First People's Hospital of Shenyang,Shenyang 110091,China;Institute of Microbial Pharmaceuticals,College of Life and Health Sciences,Northeastern University,Shenyang 110819,China;Institute of Health Sciences,Key Laboratory of Medical Cell Biology of Ministry of Education,China Medical University,Shenyang 110122,China;Liaoning University of Traditional Chinese Medicine,foreign language college,Liaoning University of Traditional Chinese Medicine,Shenyang 110033,China
Tongue and pulse features of 668 asymptomatic patients infected with the severe acute respiratory syndrome coronavirus 2 omicron variant in Shanghai
ZHANG Wen;CAO Min;SUN Ding;SHI Li;LU Wei;XU Xiangru;ZHOU Shuang;FANG Bangjiang-Department of Emergency,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Rheumatology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Pediatrics,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Nursing,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;College of Acumox and Tuina,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Emergency and Critical Care Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
Pharmacological efficacy of the traditional Chinese medicinal formula Kun-Tai-1A in the treatment of letrozole-induced polycystic ovary syndrome
Leanne Lee Leung;Jing Xie;Ya-Cun Chen;Kar-Ho Lam;Hei Wan;Su-Lan Yu;Tzi-Bun Ng;George Pak-Heng Leung;Jin Yu;Ren-Min Yao;Shu-Jia Sun;Sydney Chi-Wai Tang;Hai-Yong Chen;Jia Zhao;Zhang-Jin Zhang;Calvin Kai-Fai Lee;Kalin Yan-Bo Zhang;Li-Xing Lao;Yun Feng;Xiang Lin;Wei Meng-School of Chinese Medicine,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;School of Biomedical Sciences,Faculty of Medicine,The Chinese University of Hong Kong,Hong Kong 999077,China;Department of Pharmacology and Pharmacy,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;Workstation for Training and Research(Hong Kong Branch),Distinguished Professor Yu Jin Gynaecology of Chinese Medicine&Integrative Medicine,Hong Kong 999077,China;Shanghai Taikuntang Chinese Medicine Hospital,Shanghai 200023,China;Department of Medicine,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;Department of Obstetrics and Gynaecology,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;Virginia University of Integrative Medicine,Virginia 22031,USA;Department of Ophthalmology,Peking University Third Hospital,Beijing 100191,China;Workstation of Zhu Nansun,National Master of Chinese Medicine,Hong Kong Branch of Zhu's School of Gynaecology of Chinese Medicine from Shanghai,Hong Kong 999077,China
Olfactory and gustatory dysfunctions of COVID-19 patients in China: A multicenter study
Li Jianhui;Sun Yi;Qin Enqiang;Yuan Hu;Liu Mingbo;Yi Wenqi;Chen Zhu;Huang Chengcheng;Zhou Fengjie;Chen Ruiyao;Zhang Leibo;Yu Ning;Liu Qiong;Zhou Xuejun;He Jingjing;Li Boyu;Wang Fusheng;Yang Changliang;Yang Shiming-College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China;National Clinical Research Center for Otolaryngologic Diseases, Beijing, China;Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital Hainan Hospital, Sanya, China;Hainan Clinical Research Center for Otolaryngologic Diseases, Sanya, China;Department of Otolaryngology Head and Neck Surgery, General Hospital of Central Theater Command, Wuhan, China;Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China;National Clinical Research Center for Infectious Diseases, Beijing, China
Moxibustion for COVID-19: a systematic scoping review
Meng Xia;Bo Pang;Shaowei Yi;Xinjue Shan;Shizhe Deng;Yinan Qin;Tao Jiang;Hai Lu-Alberta College of Acupuncture&Traditional Chinese Medicine,Alberta,Canada;Evidence-based Medicine Center,TianjinUniversity of Traditional Chinese Medicine,Tianjin,China;School of Acupuncture-moxibustion and Tuina,Tianjin University of Traditional Chinese Medicine,Tianjin,China;School of Traditional ChineseMedicine,Tianjin University of Traditional Chinese Medicine,Tianjin,China;Department of Acupuncture and Moxibustion,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China;National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin,China;School of Acupuncture-moxibustion and Tuina,Shaanxi University of Chinese Medicine,Xianyang,China;Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing,China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。